Antineoplastic AgentsAntibiotics, AntineoplasticAntineoplastic Agents, PhytogenicAntineoplastic Agents, AlkylatingDrug Screening Assays, AntitumorDoxorubicinNeoplasmsLeukemia P388Antimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsPhospholipid EthersCell Line, TumorApoptosisEllipticinesGalliumBryostatinsThiadiazinesGloves, ProtectiveTumor Cells, CulturedAmaryllidaceae AlkaloidsDrug SynergismNarcissusAster PlantCell SurvivalCisplatinLeukemia L1210Occupational ExposureOlacaceaeDose-Response Relationship, DrugPaclitaxelBibenzylsMedical SecretariesOncology NursingLaunderingSulindacProtective DevicesDental Physiological ProcessesXenograft Model Antitumor AssaysDaunorubicinLactonesCell ProliferationDrug Resistance, NeoplasmEquipment and Supplies, HospitalProtective ClothingDepsipeptidesDrug Evaluation, PreclinicalCell DivisionEquipment Contamination6-MercaptopurineEpothilonesCell CycleDrug EvaluationCyclophosphamideAmsacrineHL-60 CellsFluorouracilDecontaminationNeoplasms, ExperimentalVanadium CompoundsNeoplasm TransplantationSarcoma 180PhlebitisMolecular StructureEtoposideProdrugsNursing Staff, HospitalMethotrexateMice, NudeDNA DamageEnvironmental MonitoringEnzyme InhibitorsHazardous SubstancesAncitabineInhibitory Concentration 50ThiosemicarbazonesCarcinoma, Ehrlich TumorPersonnel, HospitalFloxuridineBleomycinBreast NeoplasmsMacrolidesDrug Compounding2-PropanolAntineoplastic ProtocolsAminoacridinesTumor Stem Cell AssayLung NeoplasmsColonic NeoplasmsVincristinePharmaciesCarmustineCytarabineTopoisomerase II InhibitorsDrug Resistance, MultipleFarnesyltranstransferaseOncology Service, HospitalComet AssayDrug Administration ScheduleDrugs, InvestigationalIsocoumarins